Endo Vitd No Testing Under50

---
name: endo-vitd-no-testing-under50
description: Recommends against routine 25(OH)D testing in adults younger than 50 years. Triggers include clinician questions such as "Should I order a vitamin D level for this patient under 50?" or "Is vitamin D testing indicated for asymptomatic young adults?"
---

# Against routine vitamin D testing in adults under 50

## STEP 1 — Gather Information
Collect patient age, pregnancy status, presence of established indications for vitamin D testing (e.g., hypocalcemia, malabsorption, chronic kidney disease, osteoporosis/fracture history), and current symptoms; end with determination of whether the patient is <50 years, nonpregnant, and lacks established indications for testing.

## STEP 2 — Rule In / Rule Out
If patient is <50 years, nonpregnant, and has no established indications for vitamin D testing → Rule Out routine testing; else (age ≥50, pregnant, or has established indications) → Rule In for consideration of testing per other guidelines.

## STEP 3 — Classify or Stratify
For those ruled in, further classify by indication: hypocalcemia or metabolic bone disease (test to guide repletion), malabsorption or CKD (test to assess deficiency), pregnancy (follow prenatal vitamin D guidance), or age ≥50 (follow age‑specific supplementation/testing advice).

## STEP 4 — Decide
For patients ruled out (<50, nonpregnant, no indications): do not order routine 25(OH)D test; ensure adequate vitamin D intake via diet and safe sun exposure to meet Dietary Reference Intakes (600 IU daily for ages 19‑70); refrain from empiric supplementation beyond DRI unless other clinical indications arise.

## Clinical Guardrails / Mimics / Pitfalls
Do not test based solely on nonspecific symptoms like fatigue or myalgia; do not use 25(OH)D results to guide vitamin D dosing in this age group; avoid testing in pregnancy (different recommendations apply); do not test in patients with malabsorption, renal disease, or medications affecting vitamin D metabolism without clear indication; recognize that unnecessary testing increases costs, may lead to false‑positive results, and can result in overtreatment with associated harms.

## Concrete Clinical Example
A 35‑year‑old woman presents with mild fatigue and requests a vitamin D level; she reports no gastrointestinal symptoms, normal serum calcium, is not pregnant, and has no history of malabsorption or renal disease. After gathering information, she is <50, nonpregnant, and lacks established indications for testing. The clinician advises against routine 25(OH)D testing, reassures that fatigue evaluation should focus on other common causes, and counsels her on achieving adequate vitamin D through a balanced diet and regular outdoor activity.

**Source:** Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2024, https://doi.org/10.1210/clinem/dgae290